Schedule 13G ownership disclosure
PROTEOSTASIS THERAPEUTICS, INC.
Security class unavailable · CUSIP: 74373B109
Event date: 2016-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-16-001287
- Form type
- SC 13G
- Filer
- Cormorant Global Healthcare Master Fund, LP
- CIK
- CIK 1618442
- Filed
- Feb 26, 2016
- Reporting period
- Feb 16, 2016
- Description
- Schedule 13G beneficial ownership